Pendulum Therapeutics Expands Microbiome Research in Women's Health and Dermatology
Pendulum Therapeutics expands its long-standing clinical collaboration with Mayo Clinic to advance microbiome-based interventions in women’s health and dermatology, building on a partnership established in 2013.
Biotechnology | 11/04/2026 | By News Bureau | 133
ATLATL Partners with Daiichi Sankyo to Boost APAC Biotech Innovation
ATLATL partners with Daiichi Sankyo to accelerate APAC biotech innovation through its Super Server platform, offering integrated R&D infrastructure, technical services, and investment support.
Biotechnology | 09/04/2026 | By News Bureau | 108
Strategic Alliance Targets Faster, High-Yield Biologics Manufacturing
OneCyte and Kemp Proteins have announced a strategic partnership to deliver advanced cell line development solutions for biopharmaceutical companies globally.
Biotechnology | 06/04/2026 | By Darshana | 130
NIH Scientists Discover Safer, Highly Potent Opioid with Potential for Pain and Addiction Treatment
A newly discovered opioid compound by NIH researchers shows strong pain relief without typical addiction risks, marking a potential breakthrough in safer pain management therapies.
Biotechnology | 06/04/2026 | By News Bureau | 143
Emcure Slashes Price of Semaglutide-Based Weight Loss Drug Poviztra in India
Emcure reduces the price of its semaglutide-based drug Poviztra, aiming to make effective weight management treatment more accessible to patients across India.
Biotechnology | 04/04/2026 | By News Bureau | 142
Symeres Partners Ambagon Therapeutics to Advance Molecular Glue Research for Cancer Treatment
The collaboration will evaluate novel small-molecule “molecular glues” to target colorectal cancer and other hard-to-treat diseases, aiming to expand next-generation drug discovery approaches.
Biotechnology | 02/04/2026 | By News Bureau | 133
NJ Bio, Aji Bio-Pharma Partner to Expand Access to AJICAP Platform
The collaboration between NJ Bio and Bio Pharma aims to accelerate development of next-generation antibody–drug conjugates through advanced site-specific conjugation technology.
Biotechnology | 01/04/2026 | By News Bureau | 119
India Emerges as High-Velocity Biopharma Innovation Hub: Endiya Report
India’s biopharma sector gains momentum as policy support, innovation and cost advantages position the country as a global R&D hub.
Biotechnology | 31/03/2026 | By News Bureau | 104
Sobi Advances Tryngolza Expansion with EMA Validation for sHTG
Sobi has announced that the European Medicines Agency (EMA) has validated its application to expand the indication of Tryngolza (olezarsen) for the treatment of adults with severe hypertriglyceridemia (sHTG), defined by triglyceride levels ≥880 mg/dL (≥10 mmol/L).
Biotechnology | 31/03/2026 | By Darshana | 191
NMPA Nod for GSK's Exdensur Boosts Biologics Manufacturing Momentum
GSK plc has received approval from China’s National Medical Products Administration (NMPA) for Exdensur (depemokimab) as an add-on maintenance therapy for severe asthma with an eosinophilic phenotype in patients aged 12 years and above.
Biotechnology | 31/03/2026 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy